Dharmaraja Allimuthu

1.4k total citations · 1 hit paper
27 papers, 974 citations indexed

About

Dharmaraja Allimuthu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Dharmaraja Allimuthu has authored 27 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Dharmaraja Allimuthu's work include Bioactive Compounds and Antitumor Agents (4 papers), Metal complexes synthesis and properties (4 papers) and Metal-Catalyzed Oxygenation Mechanisms (4 papers). Dharmaraja Allimuthu is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Metal complexes synthesis and properties (4 papers) and Metal-Catalyzed Oxygenation Mechanisms (4 papers). Dharmaraja Allimuthu collaborates with scholars based in India, United States and Germany. Dharmaraja Allimuthu's co-authors include Harinath Chakrapani, Drew Adams, Amit Singh, Ashima Bhaskar, Priyanka Tyagi, Krishnaswamy Panchanatheswaran, Govindan Ravikumar, Shweta Khanna, Zita Hubler and Ilya Bederman and has published in prestigious journals such as PLoS ONE, Chemical Communications and Journal of Materials Chemistry A.

In The Last Decade

Dharmaraja Allimuthu

26 papers receiving 959 citations

Hit Papers

Role of Reactive Oxygen Species (ROS) in Therapeutics and... 2017 2026 2020 2023 2017 100 200 300 400

Peers

Dharmaraja Allimuthu
Dharmaraja Allimuthu
Citations per year, relative to Dharmaraja Allimuthu Dharmaraja Allimuthu (= 1×) peers Raj Kumar Narang

Countries citing papers authored by Dharmaraja Allimuthu

Since Specialization
Citations

This map shows the geographic impact of Dharmaraja Allimuthu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharmaraja Allimuthu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharmaraja Allimuthu more than expected).

Fields of papers citing papers by Dharmaraja Allimuthu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharmaraja Allimuthu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharmaraja Allimuthu. The network helps show where Dharmaraja Allimuthu may publish in the future.

Co-authorship network of co-authors of Dharmaraja Allimuthu

This figure shows the co-authorship network connecting the top 25 collaborators of Dharmaraja Allimuthu. A scholar is included among the top collaborators of Dharmaraja Allimuthu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dharmaraja Allimuthu. Dharmaraja Allimuthu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allimuthu, Dharmaraja, et al.. (2024). Pivotal Role of Salicylates in Tuning the Formation and Reactivity of Mn(V)=O's. European Journal of Inorganic Chemistry. 27(17). 2 indexed citations
2.
Kumar, Rakesh, Niranjan D. Chatterjee, Shweta Khanna, et al.. (2024). Redox modulator iron complexes trigger intrinsic apoptosis pathway in cancer cells. iScience. 27(6). 109899–109899. 7 indexed citations
3.
Khanna, Shweta, et al.. (2024). Tuning isatoic anhydrides’ lysine ligation chemistry for bioconjugation and drug delivery. Cell Reports Physical Science. 5(11). 102260–102260. 1 indexed citations
4.
Yadav, Dharmendra Kumar, et al.. (2024). Diazepam-based covalent modifiers of GPX4 induce ferroptosis in liver cancer cells. Chemical Communications. 60(14). 1928–1931. 4 indexed citations
5.
Allimuthu, Dharmaraja, et al.. (2024). A Cu(ii) pseudopeptide complex: a surrogate to a formal Cu(iii) species in water and an inhibitor of cancer cell proliferation. Inorganic Chemistry Frontiers. 11(16). 5172–5184.
6.
Kumar, Rakesh, et al.. (2024). Copper and Manganese Complexes of Pyridinecarboxaldimine Induce Oxidative Cell Death in Cancer Cells. ACS Applied Bio Materials. 7(10). 6696–6705. 5 indexed citations
7.
Hubler, Zita, et al.. (2022). Enhancers of Human and Rodent Oligodendrocyte Formation Predominantly Induce Cholesterol Precursor Accumulation. ACS Chemical Biology. 17(8). 2188–2200. 12 indexed citations
8.
Khanna, Shweta, Dharmendra Kumar Yadav, Grace Kaul, et al.. (2022). Nitroisobenzofuranone, a small molecule inhibitor of multidrug-resistant Staphylococcus aureus, targets peptidoglycan biosynthesis. Chemical Communications. 58(83). 11669–11672. 4 indexed citations
9.
Kumar, Pradeep, et al.. (2022). Facile synthesis of nitroamino-1,3,4-oxadiazole with azo linkage: a new family of high-performance and biosafe energetic materials. Journal of Materials Chemistry A. 10(42). 22803–22811. 50 indexed citations
10.
Hubler, Zita, et al.. (2021). Modulation of lanosterol synthase drives 24,25-epoxysterol synthesis and oligodendrocyte formation. Cell chemical biology. 28(6). 866–875.e5. 23 indexed citations
11.
Hubler, Zita, et al.. (2021). Screening Reveals Sterol Derivatives with Pro-Differentiation, Pro-Survival, or Potent Cytotoxic Effects on Oligodendrocyte Progenitor Cells. ACS Chemical Biology. 16(7). 1288–1297. 9 indexed citations
12.
Allimuthu, Dharmaraja, Zita Hubler, Fadi J. Najm, et al.. (2019). Diverse Chemical Scaffolds Enhance Oligodendrocyte Formation by Inhibiting CYP51, TM7SF2, or EBP. Cell chemical biology. 26(4). 593–599.e4. 29 indexed citations
13.
Allimuthu, Dharmaraja & Drew Adams. (2017). 2-Chloropropionamide As a Low-Reactivity Electrophile for Irreversible Small-Molecule Probe Identification. ACS Chemical Biology. 12(8). 2124–2131. 35 indexed citations
14.
Emerson, Corey C., Dharmaraja Allimuthu, Marcin Golczak, et al.. (2017). Novel chloroacetamido compound CWR-J02 is an anti-inflammatory glutaredoxin-1 inhibitor. PLoS ONE. 12(11). e0187991–e0187991. 6 indexed citations
15.
Allimuthu, Dharmaraja. (2017). Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria. Journal of Medicinal Chemistry. 60(8). 3221–3240. 472 indexed citations breakdown →
16.
Tyagi, Priyanka, Dharmaraja Allimuthu, Ashima Bhaskar, Harinath Chakrapani, & Amit Singh. (2015). Mycobacterium tuberculosis has diminished capacity to counteract redox stress induced by elevated levels of endogenous superoxide. Free Radical Biology and Medicine. 84. 344–354. 68 indexed citations
17.
Allimuthu, Dharmaraja, Charu Jain, & Harinath Chakrapani. (2014). Substituent Effects on Reactive Oxygen Species (ROS) Generation by Hydroquinones. The Journal of Organic Chemistry. 79(19). 9413–9417. 10 indexed citations
18.
Allimuthu, Dharmaraja, et al.. (2014). A phenacrylate scaffold for tunable thiol activation and release. Chemical Communications. 50(97). 15323–15326. 8 indexed citations
19.
Allimuthu, Dharmaraja, Mallika Alvala, Dharmarajan Sriram, Perumal Yogeeswari, & Harinath Chakrapani. (2012). Design, synthesis and evaluation of small molecule reactive oxygen species generators as selective Mycobacterium tuberculosis inhibitors. Chemical Communications. 48(83). 10325–10325. 33 indexed citations
20.
Khodade, Vinayak S., Dharmaraja Allimuthu, & Harinath Chakrapani. (2012). Synthesis, reactive oxygen species generation and copper-mediated nuclease activity profiles of 2-aryl-3-amino-1,4-naphthoquinones. Bioorganic & Medicinal Chemistry Letters. 22(11). 3766–3769. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026